This Article Full Text Full Text (PDF) Data Supplement All Versions of this Article: 98/7/e50    most recent 01.RES.0000218271.93076.c3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ogawa, D. Articles by Bruemmer, D. Search for Related Content PubMed PubMed Citation Articles by Ogawa, D. Articles by Bruemmer, D. Related Collections Gene regulation Smooth muscle proliferation and differentiation

(Circulation Research. 2006;98:e50.)
© 2006 American Heart Association, Inc.

UltraRapid Communications

Activation of Peroxisome Proliferator-Activated Receptor Suppresses Telomerase Activity in Vascular Smooth Muscle Cells

Daisuke Ogawa, Takashi Nomiyama, Takafumi Nakamachi, Elizabeth B. Heywood, Jeffrey F. Stone, Joel P. Berger, Ronald E. Law, Dennis Bruemmer

From the Division of Endocrinology and Molecular Medicine (D.O., T. Nomiyama, T. Nakamachi, E.B.H., J.F.S., D.B.), University of Kentucky College of Medicine, Lexington; Department of Metabolic Disorders (J.P.B.), Merck Research Laboratories, Rahway, NJ; Takeda Pharmaceuticals North America (R.E.L.), Lincolnshire, Ill.

Correspondence to Dennis Bruemmer, MD, University of Kentucky College of Medicine, Department of Internal Medicine, Division of Endocrinology and Molecular Medicine, Wethington Health Sciences Building, Room 575, 900 S Limestone St, Lexington, KY 40536-0200. E-mail Dennis.Bruemmer{at}uky.edu

Activation of the peroxisome proliferator-activated receptor (PPAR) , the molecular target for insulin sensitizing thiazolidinediones used in patients with type 2 diabetes, inhibits vascular smooth muscle cell (VSMC) proliferation and prevents atherosclerosis and neointima formation. Emerging evidence indicates that telomerase controls key cellular functions including replicative lifespan, differentiation, and cell proliferation. In the present study, we demonstrate that ligand-induced and constitutive PPAR activation inhibits telomerase activity in VSMCs. Telomerase reverse transcriptase (TERT) confers the catalytic activity of telomerase, and PPAR ligands inhibit TERT expression through a receptor-dependent suppression of the TERT promoter. 5'-deletion analysis, site-directed mutagenesis, and transactivation studies using overexpression of Ets-1 revealed that suppression of TERT transcription by PPAR is mediated through negative cross-talk with Ets-1–dependent transactivation of the TERT promoter. Chromatin immunoprecipitation assays further demonstrated that PPAR ligands inhibit Ets-1 binding to the TERT promoter, which is mediated at least in part through an inhibition of Ets-1 expression by PPAR ligands. In VSMCs overexpressing TERT, the efficacy of PPAR ligands to inhibit cell proliferation is lost, indicating that TERT constitutes an important molecular target for the antiproliferative effects of PPAR ligands. Finally, we demonstrate that telomerase activation during the proliferative response after vascular injury is effectively inhibited by PPAR ligands. These findings provide a previously unrecognized mechanism for the antiproliferative effects of PPAR ligands and support the concept that PPAR ligands may constitute a novel therapeutic approach for the treatment of proliferative cardiovascular diseases.

Key Words: telomerase • peroxisome proliferator-activated receptor • vascular smooth muscle cell • proliferation

This article has been cited by other articles:

				N. Makino, T. Maeda, J.-i. Oyama, Y. Higuchi, and K. Mimori Improving insulin sensitivity via activation of PPAR-{gamma} increases telomerase activity in the heart of OLETF rats Am J Physiol Heart Circ Physiol, December 1, 2009; 297(6): H2188 - H2195. [Abstract] [Full Text] [PDF]

				D. Meredith, M. Panchatcharam, S. Miriyala, Y.-S. Tsai, A. J. Morris, N. Maeda, G. A. Stouffer, and S. S. Smyth Dominant-Negative Loss of PPAR{gamma} Function Enhances Smooth Muscle Cell Proliferation, Migration, and Vascular Remodeling Arterioscler Thromb Vasc Biol, April 1, 2009; 29(4): 465 - 471. [Abstract] [Full Text] [PDF]

				T. Nomiyama, Y. Zhao, F. Gizard, H. M. Findeisen, E. B. Heywood, K. L. Jones, O. M. Conneely, and D. Bruemmer Deficiency of the NR4A Neuron-Derived Orphan Receptor-1 Attenuates Neointima Formation After Vascular Injury Circulation, February 3, 2009; 119(4): 577 - 586. [Abstract] [Full Text] [PDF]

				A. Farsetti, A. Grasselli, S. Bacchetti, C. Gaetano, and M. C. Capogrossi The telomerase tale in vascular aging: regulation by estrogens and nitric oxide signaling J Appl Physiol, January 1, 2009; 106(1): 333 - 337. [Abstract] [Full Text] [PDF]

				F. Gizard, T. Nomiyama, Y. Zhao, H. M. Findeisen, E. B. Heywood, K. L. Jones, B. Staels, and D. Bruemmer The PPAR{alpha}/p16INK4a Pathway Inhibits Vascular Smooth Muscle Cell Proliferation by Repressing Cell Cycle-Dependent Telomerase Activation Circ. Res., November 7, 2008; 103(10): 1155 - 1163. [Abstract] [Full Text] [PDF]

				S. Z. Duan, M. G. Usher, and R. M. Mortensen Peroxisome Proliferator-Activated Receptor-{gamma}-Mediated Effects in the Vasculature Circ. Res., February 15, 2008; 102(3): 283 - 294. [Abstract] [Full Text] [PDF]

				T. Minamino and I. Komuro Vascular Cell Senescence: Contribution to Atherosclerosis Circ. Res., January 5, 2007; 100(1): 15 - 26. [Abstract] [Full Text] [PDF]

				P. Oettgen Regulation of Vascular Inflammation and Remodeling by ETS Factors Circ. Res., November 24, 2006; 99(11): 1159 - 1166. [Abstract] [Full Text] [PDF]

				J. J. Fuster and V. Andres Telomere Biology and Cardiovascular Disease Circ. Res., November 24, 2006; 99(11): 1167 - 1180. [Abstract] [Full Text] [PDF]